Reinventing Aptamer Science: The Neomer Platform In 2022, NeoVentures Biotechnology revolutionized aptamer science by introducing reproducibility, paving the way for the next generation of aptamers. Using our neomer platform, we reduced the number of random nucleotides while preserving optimal structural diversity. This innovation addressed the… Leer más »The Next Generation of Aptamers
Ludwig Mies van der Rohe, famously said of architecture that “Less is more”. This principle is based on the idea that removing superfluous elements enhances the clarity of the concept. It emphasizes functionality, clean aesthetics and simplicity. The German pavilion that he designed for the… Leer más »Aptamer architecture: Less is more in truncations
The Enzyme-Linked Immunosorbent Assay (ELISA) was invented by Swedish scientists Eva Engvall and Peter Perlmann in 1971. This groundbreaking diagnostic method revolutionized medicine by using antibodies to detect the presence of specific hormones or viruses, providing results much faster than traditional methods. The Enzyme-Linked Immunosorbent… Leer más »The Enzyme-Linked Oligonucleotide Assay. The aptamer ELISA.
Background: By translating information on protein abundance to information on DNA abundance High-Plex proteomics brings deeper analysis than transcriptomics on a protein level. Pioneers like Olink and Somalogic have been leaders in building a future based on protein abundance. There are, however, weaknesses in the… Leer más »The Aptamarker Platform
Keys to solving problems with aptamers: Obtain good specific aptamers We think that the only way to reliably obtain aptamers that will be specific enough for commercial applications is to use our reinvented Neomer library approach. Aptamer quality should be based on scientifically stringent binding… Leer más »The NeoVentures’ Business Strategy Part 2
CRO: contract research organization. A company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. At NeoVentures, we do not consider ourselves as a (CRO). We approach what we do more as co-entrepreneurs with you. Clients come to… Leer más »The NeoVentures’ Business Strategy Part 1
In year three of the French revolution, a law was enacted to realize the rallying cry, “un roi, une loi, un poids, et une mesure” (One king, one law, one weight, and one measure) and this became the introduction of the metric system. The one… Leer más »The Importance Of What Is Difficult To Measure: How NeoVentures’ Aptamarker Platform Is Setting New Standards in Protein Measurement
Una historia incluida en Las Mil y Una Noches es la historia de Aladino. Un niño pobre que un día logra engañar al malvado hechicero y obtener la lámpara mágica. Dentro de la lámpara vive el genio, quien le concederá todos sus deseos. Ahora,... Leer más »Por qué los anticuerpos desearían ser ADN
En el dinámico ámbito de la biología molecular, la búsqueda de mejorar herramientas diagnósticas y enfoques terapéuticos es un viaje en constante evolución. Un avance significativo en esta búsqueda es el desarrollo de la biblioteca Neomer, una plataforma innovadora que permite la utilización de secuencias idénticas en diversas... Leer más »Desatando el Potencial de la Biblioteca Neomer: Un Enfoque Revolucionario para la Caracterización y Mejora de Aptámeros.
Construcción del Espacio Molecular: La plataforma de Aptamarcadores de NeoVentures Biotechnology aprovecha el análisis de Aptamarcadores para construir un espacio molecular, donde los individuos se agrupan según perfiles biomoleculares únicos. Este espacio captura la diversidad en las respuestas a enfermedades y permite la exploración matizada de diferentes procesos fisiopatológicos que llevan a la misma... Leer más »Caso de uso de Aptamarcadores: Navegando el Paisaje Molecular: Aptamarcadores como la Brújula para la Estratificación de Pacientes.
Spanish 
English 
French